Medical Journals

Stabilized Immune Modulatory Rna Compounds As Agonists of Toll-like Receptors 7 and 8.

Authors:
  • Lan Tao
  • Kandimalla Ekambar R
  • Yu Dong
  • Bhagat Lakshmi
  • Li Yukui
  • Wang Daqing
  • Zhu Fugang
  • Tang Jimmy X
  • Putta Mallikarjuna R
  • Cong YanPing
  • Trombino Anthony F
  • Sullivan Tim
  • Agrawal Sudhir

From: Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge, MA 02139, USA.

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: Aug 2007
  • ISSN: 0027-8424
  • Volume: 104
  • Issue: 34
  • Pages: 13750-5
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lan Tao, Kandimalla Ekambar R, Yu Dong, et al. Stabilized Immune Modulatory Rna Compounds As Agonists of Toll-like Receptors 7 and 8.. Proc. Natl. Acad. Sci. U.S.A. Aug 2007;104:13750-5

Abstract

Viral and synthetic single-stranded RNAs are the ligands for Toll-like receptor (TLR)7 and TLR8. However, single-stranded RNA is rapidly degraded by ubiquitous RNases, and the studies reported to date have used RNA with lipid carriers. To overcome nuclease susceptibility of RNA, we have synthesized several RNAs incorporating a range of chemical modifications. The present study describes one pool of RNA compounds, referred to as stabilized immune modulatory RNA (SIMRA) compounds, in which two RNA segments are attached through their 3’ ends. SIMRA compounds showed greater stability in human serum compared with linear RNA and activated human TLR8, but not TLR7, in HEK293 cells without using lipid carriers. Interestingly, another set of SIMRA compounds containing 7-deazaguanosine substituted for natural guanosine activated human TLR7 and TLR8. Additionally, TLR7- and TLR8-activating compounds, but not the compounds that activated only TLR8, stimulated mouse immune cells in vitro and in vivo and produced dose-dependent T helper 1-type cytokines. Both types of compounds activated human peripheral blood mononuclear cells, but only TLR7- and TLR8-activating compounds activated plasmacytoid dendritic cells and produced high levels of IFN-alpha. In monkeys, s.c. administration of both types of SIMRA compounds induced transient changes in peripheral blood monocytes and neutrophils, and activated T lymphocytes, monocytes, and NK cells. Both types of compounds induced IFN-gamma-inducible protein 10, but only the 7-deazaguanosine-containing compound that activated both TLR7 and TLR8 induced IFN-alpha in monkeys. This is a comprehensive study of RNA-based compounds containing structures and synthetic stimulatory motifs in mouse, monkey, and human systems without using lipid carriers.

Mesh Headings (Keywords): Animals, Cells, Cultured, Cytokines, Dendritic Cells, Drug Design, Humans, Immunologic Factors, Macaca fascicularis, Mice, RNA, RNA Stability, Spleen, Toll-Like Receptor 7, Toll-Like Receptor 8


Check for Full Text / PubMed Unique Identifier (PMID): 17698957


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.